Voluntary recall lot medicinal specialty “TAVOR”. Reduction of the period of validity, from 21 to 15 months

The Company Pfizer Italia Srl, in its own note received on June 1, 2016, announced that it had begun the procedure to recall batch n. 4031 expired. 30/6/2016 of the medicinal specialty TAVOR*INIET 5F 1ML 4MG/ML – AIC 022531139. This withdrawal was necessary due to the reduction of the validity period, from 21 to 15 months, of the drug in question. TAVOR is indicated in the treatment Anxiety, tension and other somatic or psychiatric manifestations associated with anxiety syndrome.

Insomnia. Benzodiazepines are indicated only when the disorder is severe, disabling and subjects the person to severe discomfort. Therefore, Pfizer, highlights Giovanni D’Agata, president of the "Sportello dei Diritti," urges to immediately suspend the dispensation of the above batch, store any stock in a safe area and prepare it for withdrawal.